Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

CLOV stock should not be bought until it has positive earnings. The company has good growth to report but needs earnings to lower the risk.

Clover Health's Earnings Losses Make It One to Avoid for Now

Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower Tuesday. The stock initially surged after the company reported better-than-expected top-line results and reaffirmed guidance, but it's pulling back significantly today.

Clover Health Was Up 15% Before Turning Lower: What's Going On?

The health insurance company's share price is popping on news of better-than-expected earnings and strong forward guidance. The post CLOV Stock Pops 15% as Hard-Hit Clover Health Grows Revenue appeared first on InvestorPlace.

CLOV Stock Pops 15% as Hard-Hit Clover Health Grows Revenue

Evaxion Biotech A/S

Mullen Automotive

Penny stocks to watch this week. The post Good Penny Stocks To Buy Now?

Good Penny Stocks To Buy Now? 4 For Your May Watch List

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2022 Results Conference Call May 9, 2022 5:00 PM ET Company Participants Derrick Nueman - Head or Investor Relations and Corporate Strategy Vivek Garipalli - CEO Andrew Toy - President Mark Herbers - Interim CFO Conference Call Participants Richard Close - Canaccord Genuity Jason Cassorla - Citi Whit Mayo - SVB Securities Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, good day and welcome to the Clover Health First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Clover Health Investments, Corp. (CLOV) CEO Vivek Garipalli on Q1 2022 Results - Earnings Call Transcript

Clover Health Investments Corp (NASDAQ: CLOV) shares are trading higher in Monday's after-hours session after the company reported better-than-expected top-line results and reaffirmed guidance. Clover Health reported first-quarter revenue of $874.4 million, which beat the $787.34-.

Why Clover Health Stock Is Surging After Hours

First quarter total revenue was $874.4 million, compared to $200.3 million in first quarter 2021

Clover Health Reports First Quarter 2022 Financial Results

FRANKLIN, Tenn., May 09, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Aric Sharp as Chief Executive Officer (“CEO”) of Value Based Care for Clover. Sharp will spearhead all value based care operations for the company including for Clover Health Partners, Clover's Direct Contracting Entity (“DCE”).

Aric Sharp Announced as Divisional CEO of Value Based Care for Clover Health

The Clover Health (NASDAQ: CLOV) stock price is hovering near its lowest level on record ahead of the company's upcoming quarterly results. The shares are trading at $2.79, which is slightly above the all-time low of $2.21, bringing its total market cap to more than $1.2 billion.

Clover Health stock price forecast ahead of Q1 earnings

Clover Health's (CLOV) first-quarter results are likely to reflect benefits from Clover Assistant management.

Clover Health (CLOV) to Report Q1 Earnings: What's in Store?

Blue Apron

Arrival Group

Penny stocks to buy according to these analysts. The post Penny Stocks To Buy According To Analysts & Price Targets Up To 900% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Buy According To Analysts & Price Targets Up To 900%

It's not for certain CLOV stock spikes after its upcoming earnings report, and a lot needs to happen for it to make a true price recovery. The post All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here appeared first on InvestorPlace.

All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here

FRANKLIN, Tenn., April 27, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Bank of America 2022 Healthcare Conference on Wednesday, May 11, 2022, at 12:20 p.m. Eastern Time.

Clover Health to Present at Bank of America 2022 Healthcare Conference on May 11, 2022

Clover is delivering improved operational results. Management's better than expected guidance lends positive outlook to CLOV stock.

Has Clover Health Finally Bottomed Out?

FuboTV

Are these stocks too cheap to pass up right now?

2 Meme Stocks That Are Down More Than 80% From Their 52-Week Highs

Clover Health has interesting technology, but unless it can end losses this year it may not have a 2023. It has great technology but may lack the financial strength to make it in the Medicare Advantage arena.

Clover Health's Technology Is Great But With Dead Money

A possible revenue stream for Clover Health is their policyholder's health data. Could that be a way to get CLOV stock out of its funk?

It's Time for Clover Health to Think Outside the Box

The Clover Health debate is a fiery one and it won't settle except in hindsight. Meanwhile, the better opportunity in CLOV stock is upside.

The Clover Health Debate Will Likely Settle With a Bullish Victory

A lack of battleground interest and and Clover Health's improving business bode well for long-term CLOV stock investors. The post Clover Health Stock Is No Longer a Meme Stock appeared first on InvestorPlace.

Clover Health Stock Is No Longer a Meme Stock

CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings.

Don't Buy CLOV Stock Ahead of Earnings Report

CLOV stock has been under heavy selling pressure, but brighter days should lie ahead as Clover Health offers insure-tech solutions. The post Clover Health Stock May Rise As Millions Could Lose Health Coverage appeared first on InvestorPlace.

Clover Health Stock May Rise As Millions Could Lose Health Coverage

FRANKLIN, Tenn., April 11, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that it will report first quarter 2022 financial results after market close on Monday, May 9, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's business and financial results.

Clover Health to Report First Quarter 2022 Financial Results on May 9, 2022

Clover Health certainly has the potential, but it carries more risks. Avoid CLOV stock at the current level.

Do Not Think of Clover Stock as a Bargain Yet

Cenntro Inc

Invesco Mortgage Capital

Which penny stocks are you watching in April? The post Are These 3 Penny Stocks Worth Investing in Right Now?

Are These 3 Penny Stocks Worth Investing in Right Now?

With CLOV stock, a better entry point could emerge between now and its next earnings report. The post Clover Stock's Recovery Could Reverse in the Short-Term appeared first on InvestorPlace.

News for Clover Health Investments Stock (CLOV)